The Library
Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making
Tools
Tools
Tools
Nichols, James D., Bogich, Tiffany L., Howerton, Emily, Bjørnstad, Ottar N., Borchering, Rebecca K., Ferrari, Matthew, Haran, Murali, Jewell, Christopher, Pepin, Kim M., Probert, William J. M., Pulliam, Juliet R. C., Runge, Michael C., Tildesley, Michael J., Viboud, Cécile and Shea, Katriona (2021) Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making. PLoS Biology, 19 (6). e3001307. doi:10.1371/journal.pbio.3001307
|
PDF
WRAP-strategic-testing-approaches-targeted-disease-monitoring-used-inform-pandemic-decision-making-Tildesley-2021.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Public Domain Dedication. Download (1495Kb) | Preview |
Official URL: http://dx.doi.org/10.1371/journal.pbio.3001307
Abstract
More than 1.6 million Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) tests were administered daily in the United States at the peak of the epidemic, with a significant focus on individual treatment. Here, we show that objective-driven, strategic sampling designs and analyses can maximize information gain at the population level, which is necessary to increase situational awareness and predict, prepare for, and respond to a pandemic, while also continuing to inform individual treatment. By focusing on specific objectives such as individual treatment or disease prediction and control (e.g., via the collection of population-level statistics to inform lockdown measures or vaccine rollout) and drawing from the literature on capture–recapture methods to deal with nonrandom sampling and testing errors, we illustrate how public health objectives can be achieved even with limited test availability when testing programs are designed a priori to meet those objectives.
| Item Type: | Journal Article | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subjects: | R Medicine > RA Public aspects of medicine | ||||||||||||||||||||||||||||||||||||
| Divisions: | Faculty of Science > Life Sciences (2010- ) Faculty of Science > Mathematics |
||||||||||||||||||||||||||||||||||||
| Library of Congress Subject Headings (LCSH): | COVID-19 (Disease) -- Prevention, Vaccines -- Development, COVID-19 (Disease) -- Epidemiology | ||||||||||||||||||||||||||||||||||||
| Journal or Publication Title: | PLoS Biology | ||||||||||||||||||||||||||||||||||||
| Publisher: | Public Library of Science | ||||||||||||||||||||||||||||||||||||
| ISSN: | 1545-7885 | ||||||||||||||||||||||||||||||||||||
| Official Date: | 17 June 2021 | ||||||||||||||||||||||||||||||||||||
| Dates: |
|
||||||||||||||||||||||||||||||||||||
| Volume: | 19 | ||||||||||||||||||||||||||||||||||||
| Number: | 6 | ||||||||||||||||||||||||||||||||||||
| Article Number: | e3001307 | ||||||||||||||||||||||||||||||||||||
| DOI: | 10.1371/journal.pbio.3001307 | ||||||||||||||||||||||||||||||||||||
| Status: | Peer Reviewed | ||||||||||||||||||||||||||||||||||||
| Publication Status: | Published | ||||||||||||||||||||||||||||||||||||
| Access rights to Published version: | Open Access | ||||||||||||||||||||||||||||||||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
